Form 4: Maravai LifeSciences Executive Buzzeo Reports Stock Transaction
SEC Form 4 Filing
Rebecca Buzzeo, Chief Commercial Officer of Maravai LifeSciences, reports disposition of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On March 17, 2025, Rebecca Buzzeo, Chief Commercial Officer of Maravai LifeSciences Holdings, Inc., disposed of 4,314 shares of Class A Common Stock.
- The shares were disposed of at a price of $2.64 per share.
- This transaction was to satisfy tax withholding obligations related to the vesting of restricted stock unit awards.
- Following the transaction, Buzzeo beneficially owns 310,933 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction related to executive compensation and tax obligations, with no inherent positive or negative implications for the company's overall performance or outlook.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard transaction related to tax obligations on vested equity.
Key Dates
| Date | Description |
|---|---|
| 03/17/2025 | Date of stock transaction (disposal of shares). |
| 03/19/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Maravai LifeSciences, MRVI, Rebecca Buzzeo, Stock Transaction, Chief Commercial Officer, Beneficial Ownership, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.